Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin Pamoate in Children With Precocious Puberty
NCT00564850Phase 3Completed
- Sponsor
- Ipsen
- Start
- Oct 2007
- Primary completion
- Oct 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in central precocious puberty (CPP), sponsored by Ipsen. Started Oct 2007; status: completed.
02
Drugs
triptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT00564850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564850.